{"id":440,"date":"2026-02-28T08:49:01","date_gmt":"2026-02-28T08:49:01","guid":{"rendered":"https:\/\/heartcareforyou.in\/blog\/restrictive-cardiomyopathy-definition-clinical-context-and-cardiology-overview\/"},"modified":"2026-02-28T08:49:01","modified_gmt":"2026-02-28T08:49:01","slug":"restrictive-cardiomyopathy-definition-clinical-context-and-cardiology-overview","status":"publish","type":"post","link":"https:\/\/heartcareforyou.in\/blog\/restrictive-cardiomyopathy-definition-clinical-context-and-cardiology-overview\/","title":{"rendered":"Restrictive Cardiomyopathy: Definition, Clinical Context, and Cardiology Overview"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Restrictive Cardiomyopathy Introduction (What it is)<\/h2>\n\n\n\n<p>Restrictive Cardiomyopathy is a heart muscle condition where the ventricles become stiff and fill poorly during diastole.<br\/>\nIt is a <strong>cardiomyopathy<\/strong> (a disease of the myocardium, or heart muscle) that primarily causes <strong>diastolic dysfunction<\/strong>.<br\/>\nIt is commonly encountered when evaluating <strong>heart failure symptoms with a relatively preserved ejection fraction<\/strong>.<br\/>\nIt often enters cardiology discussions alongside infiltrative diseases, arrhythmias, and unexplained right-sided congestion.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why Restrictive Cardiomyopathy matters in cardiology (Clinical relevance)<\/h2>\n\n\n\n<p>Restrictive Cardiomyopathy matters because it can produce severe congestion and exercise limitation even when the heart\u2019s pumping function (systolic function) appears relatively preserved on imaging. Clinically, it is a high-impact diagnosis: the underlying cause can range from potentially treatable disorders (such as iron overload) to progressive infiltrative diseases (such as amyloidosis), and management priorities differ accordingly.<\/p>\n\n\n\n<p>From a diagnostic standpoint, Restrictive Cardiomyopathy is also important because it overlaps with other conditions that can look similar at the bedside\u2014especially <strong>constrictive pericarditis<\/strong> (a pericardial disease that limits filling). Distinguishing myocardial restriction from pericardial constriction shapes downstream testing, risk stratification, and long-term planning.<\/p>\n\n\n\n<p>Educationally, it provides a clear framework for integrating physiology (ventricular compliance and filling pressures), imaging interpretation (Doppler filling patterns, atrial size, tissue characterization), and clinical reasoning (systemic clues such as neuropathy, renal disease, eosinophilia, or sarcoid features).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Classification \/ types \/ variants<\/h2>\n\n\n\n<p>Restrictive Cardiomyopathy is typically categorized by <strong>etiology<\/strong> (the underlying cause), because the mechanism and prognosis vary by disease process. Common etiologic groupings include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Infiltrative cardiomyopathies<\/strong><\/li>\n<li><strong>Amyloidosis<\/strong> (deposition of misfolded proteins within the myocardium)<\/li>\n<li><strong>Sarcoidosis<\/strong> (granulomatous inflammation that may involve myocardium and conduction tissue)<\/li>\n<li><strong>Storage and metabolic diseases<\/strong><\/li>\n<li><strong>Hemochromatosis<\/strong> (iron overload affecting multiple organs, including the heart)<\/li>\n<li>Other rarer storage disorders (varies by clinician and case)<\/li>\n<li><strong>Endomyocardial and fibrotic processes<\/strong><\/li>\n<li><strong>Endomyocardial fibrosis<\/strong> (fibrosis that can involve ventricular apices and inflow tracts)<\/li>\n<li><strong>Hypereosinophilic syndrome-related disease<\/strong> (eosinophil-mediated injury progressing to thrombosis and fibrosis)<\/li>\n<li><strong>Post-treatment or iatrogenic causes<\/strong><\/li>\n<li><strong>Radiation-associated heart disease<\/strong> (fibrosis affecting myocardium, valves, pericardium, and coronaries)<\/li>\n<li>Certain medication-related toxicities may contribute in selected contexts (varies by protocol and patient factors)<\/li>\n<li><strong>Idiopathic Restrictive Cardiomyopathy<\/strong><\/li>\n<li>Used when a restrictive physiology is present and no clear cause is identified after reasonable evaluation<\/li>\n<\/ul>\n\n\n\n<p>A related \u201cvariant\u201d concept is <strong>restrictive physiology<\/strong>, which can be seen transiently or in other diseases (for example, advanced hypertrophic cardiomyopathy or severe myocardial fibrosis). Clinicians may describe the physiology even when the formal diagnostic label is nuanced.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Relevant anatomy &amp; physiology<\/h2>\n\n\n\n<p>Understanding Restrictive Cardiomyopathy starts with diastole. The ventricles (left ventricle and right ventricle) normally relax and expand to accept blood at low pressure. This property is sometimes described as <strong>compliance<\/strong> (how easily the chamber stretches) and <strong>relaxation<\/strong> (active cellular processes that allow the myocardium to loosen after contraction).<\/p>\n\n\n\n<p>Key physiologic consequences of a stiff ventricle include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Elevated filling pressures<\/strong><\/li>\n<li>The atria must generate higher pressures to fill the ventricles.<\/li>\n<li>This often leads to <strong>biatrial enlargement<\/strong>, a common imaging clue.<\/li>\n<li><strong>Pulmonary and systemic venous congestion<\/strong><\/li>\n<li>Left-sided filling pressure elevation contributes to pulmonary venous hypertension and dyspnea.<\/li>\n<li>Right-sided filling pressure elevation contributes to peripheral edema, hepatic congestion, and ascites.<\/li>\n<li><strong>Relatively preserved systolic function early on<\/strong><\/li>\n<li>Ejection fraction may be normal or near-normal, especially in early or mid-stage disease.<\/li>\n<li>Stroke volume can still be limited because filling is restricted, particularly during exertion.<\/li>\n<li><strong>Valve and conduction system interactions<\/strong><\/li>\n<li>The mitral and tricuspid valves may be structurally normal, yet Doppler flows show abnormal filling patterns.<\/li>\n<li>The conduction system can be involved in infiltrative\/inflammatory causes, leading to atrioventricular (AV) block or ventricular arrhythmias (more typical in some etiologies, such as sarcoidosis).<\/li>\n<\/ul>\n\n\n\n<p>Coronary circulation is not the primary driver, but ischemia can coexist and complicate symptoms. In some infiltrative diseases, microvascular dysfunction is discussed as a contributor to angina-like symptoms (varies by clinician and case).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Pathophysiology or mechanism<\/h2>\n\n\n\n<p>The core mechanism of Restrictive Cardiomyopathy is <strong>reduced ventricular compliance<\/strong>, producing <strong>impaired diastolic filling<\/strong> and <strong>elevated end-diastolic pressures<\/strong>. The ventricle becomes less distensible because the myocardium is infiltrated, inflamed, fibrosed, or scarred.<\/p>\n\n\n\n<p>A simplified sequence is:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Myocardial stiffness increases<\/strong> due to infiltration (e.g., amyloid), inflammation and scarring (e.g., sarcoid), or fibrosis (e.g., radiation, endomyocardial fibrosis).<\/li>\n<li><strong>Early diastolic filling may be rapid<\/strong>, but the ventricle reaches its \u201cstiff limit\u201d quickly.<\/li>\n<li><strong>Filling pressures rise<\/strong>, causing atrial remodeling and venous congestion.<\/li>\n<li><strong>Atrial dilation promotes atrial arrhythmias<\/strong>, particularly atrial fibrillation (AF).<\/li>\n<li><strong>Exercise intolerance develops<\/strong> because the heart cannot increase stroke volume effectively when demand rises.<\/li>\n<\/ol>\n\n\n\n<p>Some etiologies add distinct mechanisms:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Amyloidosis:<\/strong> protein deposition thickens and stiffens myocardium; small vessel involvement and autonomic dysfunction may contribute to hypotension or syncope (varies by patient factors).<\/li>\n<li><strong>Sarcoidosis:<\/strong> patchy inflammation and scarring can impair both diastolic and systolic function and disrupt conduction, creating arrhythmia risk.<\/li>\n<li><strong>Hypereosinophilic syndrome:<\/strong> myocardial injury may progress from inflammation to mural thrombosis and then to endocardial fibrosis, leading to restrictive filling and embolic risk.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical presentation or indications<\/h2>\n\n\n\n<p>Restrictive Cardiomyopathy is commonly considered in these clinical scenarios:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Progressive <strong>exertional dyspnea<\/strong> and reduced exercise tolerance<\/li>\n<li><strong>Fatigue<\/strong> out of proportion to apparent systolic function<\/li>\n<li>Signs of <strong>right-sided congestion<\/strong>: peripheral edema, abdominal distension\/ascites, early satiety, hepatic congestion<\/li>\n<li><strong>Orthopnea<\/strong> or paroxysmal nocturnal dyspnea due to elevated left-sided filling pressures<\/li>\n<li><strong>Atrial fibrillation<\/strong> or other atrial tachyarrhythmias, sometimes as the first clue<\/li>\n<li><strong>Syncope or presyncope<\/strong>, particularly when conduction disease or autonomic dysfunction is present (varies by etiology)<\/li>\n<li><strong>Unexplained biatrial enlargement<\/strong> on echocardiography<\/li>\n<li>Systemic clues suggesting a specific cause, such as neuropathy, proteinuria, inflammatory disease features, iron overload manifestations, or eosinophilia (context-dependent)<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Diagnostic evaluation &amp; interpretation<\/h2>\n\n\n\n<p>Diagnosis is usually a combination of <strong>clinical context + imaging showing restrictive physiology + etiologic workup<\/strong>. No single test defines all cases, and evaluation is individualized.<\/p>\n\n\n\n<p>Common components include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>History and physical examination<\/strong><\/li>\n<li>Focus on congestion pattern (right- vs left-sided), tempo of symptoms, and systemic features (neurologic, renal, inflammatory, hematologic).<\/li>\n<li>Examine for jugular venous distension, hepatomegaly, ascites, edema, and signs of low output.<\/li>\n<li><strong>Electrocardiogram (ECG)<\/strong><\/li>\n<li>May show atrial fibrillation, conduction delays, or low QRS voltage in some infiltrative processes (not universal).<\/li>\n<li>Conduction disease and ventricular ectopy can raise suspicion for inflammatory\/scar-related etiologies.<\/li>\n<li><strong>Laboratory testing (etiology-directed)<\/strong><\/li>\n<li>Natriuretic peptides and cardiac troponin may assist with assessment of cardiac stress\/injury but are not specific.<\/li>\n<li>Etiologic evaluation may include iron studies, inflammatory markers, eosinophil count, and testing for monoclonal proteins when amyloidosis is suspected (testing choices vary by clinician and case).<\/li>\n<li><strong>Transthoracic echocardiography (TTE)<\/strong><\/li>\n<li>Often the first-line imaging test.<\/li>\n<li>Typical findings include normal or near-normal ventricular size, increased wall thickness in some infiltrative diseases, and <strong>biatrial enlargement<\/strong>.<\/li>\n<li>Doppler assessment may show a <strong>restrictive filling pattern<\/strong> and abnormal tissue Doppler signals consistent with impaired relaxation and high filling pressures.<\/li>\n<li>Strain imaging can provide supportive patterns for certain etiologies (interpretation is specialized and context-dependent).<\/li>\n<li><strong>Cardiac magnetic resonance (CMR) imaging<\/strong><\/li>\n<li>Useful for tissue characterization (edema, fibrosis, infiltration) and patterns of late gadolinium enhancement.<\/li>\n<li>Particularly helpful when echocardiography suggests restriction but the cause is uncertain.<\/li>\n<li><strong>Nuclear imaging and specialized studies<\/strong><\/li>\n<li>May be used in specific etiologic pathways (for example, some amyloidosis workups use targeted imaging approaches; protocols vary).<\/li>\n<li><strong>Cardiac catheterization (in selected cases)<\/strong><\/li>\n<li>Hemodynamics can demonstrate elevated filling pressures and help differentiate restrictive cardiomyopathy from constrictive pericarditis.<\/li>\n<li>Interpretation depends on respiratory variation, ventricular interdependence, and the overall clinical picture.<\/li>\n<li><strong>Endomyocardial biopsy (in selected cases)<\/strong><\/li>\n<li>Considered when a tissue diagnosis would change management and noninvasive testing is insufficient.<\/li>\n<li>Diagnostic yield and risk considerations vary by center and patient factors.<\/li>\n<\/ul>\n\n\n\n<p>A key interpretive task is distinguishing Restrictive Cardiomyopathy from <strong>constrictive pericarditis<\/strong>. Both limit filling and cause congestion, but the anatomic site of restriction (myocardium vs pericardium) differs, and that difference can substantially alter management pathways.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Management overview (General approach)<\/h2>\n\n\n\n<p>Management is generally organized around two parallel goals: <strong>treating congestion and symptoms<\/strong> and <strong>addressing the underlying cause when possible<\/strong>. Plans are individualized based on etiology, rhythm status, blood pressure tolerance, kidney function, and comorbidities.<\/p>\n\n\n\n<p>Common elements include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>General heart failure and congestion management<\/strong><\/li>\n<li>Diuretics are often used to relieve volume overload, with careful balancing to avoid reducing preload excessively in a stiff ventricle (the \u201cright\u201d balance varies by clinician and case).<\/li>\n<li>Salt and fluid guidance may be discussed in clinical care, but recommendations are individualized and protocol-dependent.<\/li>\n<li><strong>Rhythm and rate management<\/strong><\/li>\n<li>Atrial fibrillation can worsen filling by eliminating atrial contribution to ventricular filling and by causing tachycardia.<\/li>\n<li>Clinicians may prioritize rate control and rhythm strategies depending on symptoms, chronicity, and underlying substrate (varies by case).<\/li>\n<li>Anticoagulation considerations depend on rhythm status and overall thromboembolic risk; practice is individualized.<\/li>\n<li><strong>Etiology-specific therapies (when applicable)<\/strong><\/li>\n<li><strong>Amyloidosis:<\/strong> management may include disease-modifying therapy guided by subtype and specialty input; supportive cardiac care remains central.<\/li>\n<li><strong>Hemochromatosis:<\/strong> reducing iron burden can improve systemic disease and may improve cardiac involvement when treated earlier (response varies).<\/li>\n<li><strong>Sarcoidosis:<\/strong> immunosuppressive therapy may be considered when active inflammation is present; arrhythmia surveillance is often relevant (protocols vary).<\/li>\n<li><strong>Hypereosinophilic syndrome\/endomyocardial disease:<\/strong> approaches may target eosinophilia and manage thrombotic\/fibrotic complications (highly individualized).<\/li>\n<li><strong>Device therapy and advanced heart failure options<\/strong><\/li>\n<li>Pacemakers may be needed for clinically significant conduction disease.<\/li>\n<li>Implantable cardioverter-defibrillators (ICDs) may be considered in selected patients at elevated arrhythmic risk; selection criteria depend on etiology and guideline context.<\/li>\n<li>Advanced therapies such as transplant evaluation may be considered in progressive, refractory cases; candidacy depends on systemic involvement and center criteria.<\/li>\n<li>Mechanical circulatory support can be challenging in restrictive physiology and infiltrative disease; feasibility varies by patient factors and institutional expertise.<\/li>\n<\/ul>\n\n\n\n<p>Because many causes are systemic, care often involves a multidisciplinary team (cardiology plus hematology, rheumatology, oncology, or genetics as relevant).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Complications, risks, or limitations<\/h2>\n\n\n\n<p>Common complications and limitations associated with Restrictive Cardiomyopathy include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Progressive heart failure symptoms<\/strong><\/li>\n<li>Congestion can become difficult to manage as filling pressures remain high despite preserved ejection fraction.<\/li>\n<li><strong>Atrial arrhythmias<\/strong><\/li>\n<li>Atrial fibrillation and flutter are common due to atrial dilation and elevated atrial pressures.<\/li>\n<li><strong>Thromboembolism<\/strong><\/li>\n<li>Risk is often increased with atrial fibrillation and atrial mechanical dysfunction; magnitude varies by case and etiology.<\/li>\n<li><strong>Conduction disease<\/strong><\/li>\n<li>AV block or bundle branch block can occur, particularly in inflammatory\/infiltrative etiologies.<\/li>\n<li><strong>Ventricular arrhythmias and sudden cardiac death risk<\/strong><\/li>\n<li>Risk depends strongly on underlying cause (for example, scar-related substrates) and overall cardiac involvement.<\/li>\n<li><strong>Pulmonary hypertension<\/strong><\/li>\n<li>May develop secondary to chronically elevated left-sided filling pressures; this can worsen right ventricular function.<\/li>\n<li><strong>Medication tolerance limitations<\/strong><\/li>\n<li>Low blood pressure, autonomic dysfunction, and kidney disease (common in some etiologies) can limit standard heart failure medication strategies.<\/li>\n<li><strong>Diagnostic limitations<\/strong><\/li>\n<li>Noninvasive tests may suggest restriction without clearly identifying cause, and definitive diagnosis sometimes requires specialized imaging or biopsy (case-dependent).<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Prognosis &amp; follow-up considerations<\/h2>\n\n\n\n<p>Prognosis in Restrictive Cardiomyopathy is highly <strong>etiology-dependent<\/strong> and influenced by the degree of diastolic impairment, presence of arrhythmias, right ventricular involvement, pulmonary hypertension, kidney function, and systemic disease burden.<\/p>\n\n\n\n<p>Some causes may stabilize or improve when the underlying driver is treated, particularly if identified earlier in the disease course. Other forms are more progressive, with increasing congestion, arrhythmia burden, and functional decline. Even within the same etiology, outcomes vary due to differences in systemic involvement and response to therapy.<\/p>\n\n\n\n<p>Follow-up commonly focuses on:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Symptom trajectory and volume status<\/strong> (congestion patterns over time)<\/li>\n<li><strong>Rhythm monitoring<\/strong> for atrial fibrillation and clinically significant conduction disease<\/li>\n<li><strong>Serial imaging<\/strong> (often echocardiography) to reassess filling patterns, atrial size, valve function, and pulmonary pressures<\/li>\n<li><strong>Etiology-specific monitoring<\/strong>, such as markers of systemic disease activity or treatment response (varies by protocol and patient factors)<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Restrictive Cardiomyopathy Common questions (FAQ)<\/h2>\n\n\n\n<p><strong>Q: What does Restrictive Cardiomyopathy mean in plain language?<\/strong><br\/>\nIt means the heart\u2019s main pumping chambers are stiff and do not relax well. Because the chambers cannot expand normally, pressures rise when blood tries to fill the heart. Symptoms often come from congestion rather than weak squeezing early on.<\/p>\n\n\n\n<p><strong>Q: Is Restrictive Cardiomyopathy the same as heart failure?<\/strong><br\/>\nIt can cause heart failure symptoms, especially congestion and exercise intolerance. Many patients have a preserved or near-preserved ejection fraction, so it may not look like \u201cweak heart pump\u201d on a basic summary. Clinicians often describe it as a form of heart failure dominated by diastolic dysfunction.<\/p>\n\n\n\n<p><strong>Q: How is Restrictive Cardiomyopathy different from hypertrophic cardiomyopathy?<\/strong><br\/>\nHypertrophic cardiomyopathy (HCM) usually features abnormal thickening of the heart muscle with characteristic patterns and sometimes obstruction of outflow. Restrictive Cardiomyopathy is defined more by impaired filling from stiffness, and wall thickening may or may not be present depending on the cause. The etiologies and risk profiles can differ substantially.<\/p>\n\n\n\n<p><strong>Q: How is Restrictive Cardiomyopathy different from constrictive pericarditis?<\/strong><br\/>\nRestrictive Cardiomyopathy is a myocardial problem (the muscle is stiff), while constrictive pericarditis is a pericardial problem (the sac around the heart limits expansion). They can look similar clinically with swelling and elevated neck veins. Imaging and sometimes invasive hemodynamics help distinguish them because management pathways differ.<\/p>\n\n\n\n<p><strong>Q: Can the ejection fraction be normal in Restrictive Cardiomyopathy?<\/strong><br\/>\nYes. Ejection fraction measures the percentage of blood ejected, not how well the ventricle relaxes or how much blood fills. In restrictive physiology, the heart may eject a normal percentage of a smaller filled volume, so symptoms can still be significant.<\/p>\n\n\n\n<p><strong>Q: What tests are commonly used to confirm the diagnosis?<\/strong><br\/>\nEchocardiography is usually the first key test because it assesses chamber sizes, filling patterns, and pressures indirectly. Cardiac magnetic resonance can add tissue characterization and help identify infiltration or scarring. Additional blood tests and, in selected cases, biopsy or catheterization may be used to determine the cause.<\/p>\n\n\n\n<p><strong>Q: Is Restrictive Cardiomyopathy genetic?<\/strong><br\/>\nSome restrictive phenotypes can have genetic contributions, but many common causes are acquired (such as amyloidosis subtypes, inflammation, iron overload, or radiation effects). Whether genetic evaluation is appropriate varies by presentation, family history, and suspected etiology. Clinicians often tailor evaluation to the most likely causes.<\/p>\n\n\n\n<p><strong>Q: What are the main treatment goals?<\/strong><br\/>\nThe main goals are to reduce congestion, manage arrhythmias, and treat the underlying disease when a specific cause is identified. Because a stiff ventricle can be sensitive to changes in preload and blood pressure, treatment plans are individualized. In advanced cases, referral for specialized heart failure care may be part of the broader plan.<\/p>\n\n\n\n<p><strong>Q: What does follow-up typically involve?<\/strong><br\/>\nFollow-up often includes reassessing symptoms, checking for recurrent fluid retention, and monitoring heart rhythm. Repeat imaging may be used to track filling patterns and pulmonary pressure estimates. Additional follow-up depends on the underlying cause and any disease-specific therapy being used.<\/p>\n\n\n\n<p><strong>Q: Can people with Restrictive Cardiomyopathy return to normal activities or exercise?<\/strong><br\/>\nActivity tolerance varies widely based on severity, rhythm status, and the underlying cause. Some people maintain reasonable daily function, while others have more limiting symptoms. Clinicians typically individualize activity guidance based on symptoms, hemodynamics, and arrhythmia risk rather than using a single universal rule.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Restrictive Cardiomyopathy is a heart muscle condition where the ventricles become stiff and fill poorly during diastole. It is a **cardiomyopathy** (a disease of the myocardium, or heart muscle) that primarily causes **diastolic dysfunction**. It is commonly encountered when evaluating **heart failure symptoms with a relatively preserved ejection fraction**. It often enters cardiology discussions alongside infiltrative diseases, arrhythmias, and unexplained right-sided congestion.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-440","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/440","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/comments?post=440"}],"version-history":[{"count":0,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/440\/revisions"}],"wp:attachment":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/media?parent=440"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/categories?post=440"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/tags?post=440"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}